CINECA IRIS Institutional Research Information System

GUERRINI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.252
EU - Europa 2.018
AS - Asia 693
AF - Africa 93
OC - Oceania 18
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.087
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.163
IT - Italia 780
SE - Svezia 482
CN - Cina 315
GB - Regno Unito 222
BG - Bulgaria 172
DE - Germania 164
SG - Singapore 115
VN - Vietnam 112
CA - Canada 86
TR - Turchia 66
CI - Costa d'Avorio 54
FI - Finlandia 51
UA - Ucraina 33
FR - Francia 29
BE - Belgio 26
SN - Senegal 26
AU - Australia 18
HK - Hong Kong 18
IN - India 17
KR - Corea 17
PH - Filippine 16
RU - Federazione Russa 15
CH - Svizzera 12
BR - Brasile 9
ES - Italia 9
NG - Nigeria 9
JP - Giappone 8
NL - Olanda 5
CZ - Repubblica Ceca 4
GR - Grecia 4
EU - Europa 3
MY - Malesia 3
BT - Bhutan 2
HR - Croazia 2
IE - Irlanda 2
MX - Messico 2
PL - Polonia 2
TH - Thailandia 2
AT - Austria 1
BJ - Benin 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
IL - Israele 1
IR - Iran 1
PA - Panama 1
RO - Romania 1
TN - Tunisia 1
UY - Uruguay 1
Totale 6.087
Salva come PNG Salva come JPEG
Città #
Serra 388
Woodbridge 365
Fairfield 359
Ann Arbor 271
Houston 267
Chandler 260
Ashburn 203
Seattle 193
Sofia 170
Wilmington 146
Beijing 144
Cambridge 125
New York 106
Milan 93
Boardman 91
Princeton 86
Ottawa 74
London 65
Florence 62
Medford 60
Izmir 59
Lawrence 59
Abidjan 54
Jacksonville 42
Des Moines 41
Singapore 39
Dearborn 35
Nanjing 35
Dong Ket 27
San Diego 27
Dakar 26
Lancaster 23
Pisa 23
Brussels 21
Bremen 20
Redwood City 20
Nanchang 19
Hong Kong 18
Rome 18
Los Angeles 13
Alessandria 12
Shenyang 12
Changsha 11
Hefei 10
Manila 10
Duncan 9
Lagos 9
Bern 8
Hebei 8
Jüchen 8
Melbourne 8
Boulder 7
Dallas 7
Jiaxing 7
Kunming 7
Norwalk 7
Cascina 6
Düsseldorf 6
Falls Church 6
Frankfurt am Main 6
Hangzhou 6
Nürnberg 6
Perth 6
Washington 6
Westminster 6
Charlottetown 5
Chengdu 5
East Lansing 5
Helsinki 5
Palermo 5
Phoenix 5
Seocho-gu 5
Tianjin 5
Zhengzhou 5
Leawood 4
Leeds 4
Livorno 4
Ogden 4
Seongnam-si 4
Auburn Hills 3
Aydin 3
Changchun 3
Chiavari 3
Chiswick 3
Ho Chi Minh City 3
Jinan 3
Kent 3
Kocaeli 3
Lincoln 3
Mombaruzzo 3
Moscow 3
San Jose 3
Selargius 3
Trento 3
Ypsilanti 3
Zurich 3
Anagni 2
Assenede 2
Billericay 2
Boston 2
Totale 4.465
Salva come PNG Salva come JPEG
Nome #
The perception of stress in cat owners 196
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen. Leuk Lymphoma 187
Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study. 152
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines 149
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen 143
The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia 140
A PRACTICAL APPROACH TO THERAPEUTIC DRUG MONITORING OF IMATINIB IN PATIENTS AFFECTED BY CHRONIC MYELOID ELEUKEMIA. THE TIKLET PROTOCOL. 135
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia 134
Polycomb genes are associated with response to imatinib in chronic myeloid leukemia 129
Reduced circulating B-lymphocytes and altered B-cell compartments in patients suffering from chronic myeloid leukaemia undergoing therapy with Imatinib 128
Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders. 126
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 125
Combined unfavourable polymorphisms ofhOCT1 and ABCG2 are responsible for delayed complete cytogenetic response during imatinib treatment. 125
Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment 125
TCR REARRANGEMENTS ARE NOT ENOUGH FOR DISTINGUISHING THE CHURG-STRAUSS SYNDROME FROM THE HYPEREOSINOPHILIC SYNDROME 124
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines 123
PLATELET-DERIVED GROWTH FACTOR BETA RECEPTOR (PDGFRB) GENE IS REARRANGED IN A SIGNIFICANT PERCENTAGE OF MYELODYSPLASTIC SYNDROMES WITH NORMAL KARYOTYPE 123
Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosis 121
Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: The FIL FOLL05 trial 118
MDS: An Integrated Workup for a Correct Diagnosis 117
Transmembrane Transporters hOCT1 and SLCO1B3 Polymorphisms Could Have a Role in Patients Affected By Chronic Myeloid Leukemia Treated with Nilotinib 112
Comparison of Real-Time PCR and Droplet Digital PCR for the Determination of JAK2V617F Mutation in Ph'-Negative Myeloproliferative Neoplasms 107
LOW RPS14 EXPRESSION IS FREQUENTLY FOUND IN NON-5Q-MYELODYSPLASTIC SYNDROMES 105
Droplet digital PCR represents a new sensitive method for detecting B-RAFV600E mutation at diagnosis and during the follow-up of patients affected by hairy cell leukemia 104
High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naïve lymphocytes and prevents TTV reactivation 104
Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients 103
Molecular detection of GNNK- and GNNK+ c-kit isoforms: a new tool for risk stratification in adult acute myeloid leukaemia 101
Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup 100
The combination of rituximab and bendamustine as first-line treatment is highly effective in the eradicating minimal residual disease in follicular lymphoma: An Italian retrospective study 100
Increased values of the circulating PDGFβ sustains the "withdrawal syndrome" after tyrosine kinase inhibitor discontinuation in patients affected by chronic myeloid leukemia 99
Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation 98
A Novel Digital PCR Assay for MYD88 L265P Mutation Detection in Waldenstrom Macroglobulinemia: Minimal Residual Disease Monitoring and Characterization on Circulating Free DNA 98
The WNT pathway is relevant for the BCR-ABL1-independent resistance in chronic myeloid leukemia 98
Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab 95
WT1 expression levels at diagnosis could predict long-term time-to-progression in adult patients affected by acute myeloid leukaemia and myelodysplastic syndromes 95
Combined FAMD and ANOVA investigation leads to significant association between the hOCT1/ABCB1 diplotype and both efficacy and tolerability in patients affected by chronic myeloid leukemia 94
Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line 92
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EGPA FROM HES 88
Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patients 82
Myelodysplastic Syndromes: A Multidisciplinary Integrated Diagnostic Work-up for Patients' Risk Stratification 78
PRDI-BF1 and PRDI-BF1P isoform expressions correlate with disease status in multiple myeloma patients 78
The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia 78
Platelet-derived growth factor beta receptor (PDGFRB) gene is rearranged in a significant percentage of myelodysplastic syndromes with normal karyotype 77
The clinical relevance of the expression of several multidrug-resistant-related genes in patients with primary acute myeloid leukemia 76
ZINC ORAL SUPPLEMENTATION INDUCES A SIGNIFICANT RISE OF TRECS AND T CD4+ NAΪVE AND PREVENTS THE INCREASE OF TTV VIRAL LOAD AFTER STEM CELL TRANSPLANTATION: THE ZENITH STUDY 76
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EOSINOPHILOIA IN EGPA FROM HES 75
The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients 74
ITF2357 interferes with apoptosis and inflammatory pathways in the HL-60 model: a gene expression study. 73
Conventional Cytogenetics, ACGH, and PCR as Integrated Workup for a Correct Diagnosis of MDS 71
The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice 71
FLT3 mutations do not influence MDR-1 gene expression in acute myeloid leukemia 69
The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma 68
R-IPSS, RPS14 AND WT1 LEVELS ARE THE BEST PROGNOSTIC FACTORS FOR PATIENTS AFFECTED BY MYELODYSPLASTIC SYNDROMES DURING AZACITIDINE TREATMENT. 68
THE C.480C>G POLYMORPHISM OF HOCT1 TRANSPORTER INFLUENCES IMATINIB CLEARANCE IN PATIENTS AFFECTED BY CHRONIC MYELOID LEUKEMIA 67
Altered Expression of Jak-Stat Pathway as Possible Predictive Marker in Patients Affected by Chronic Myeloid Leukemia Receiving Tyrosin Kinase Inhibitors (TKIS) 67
Quantitative molecular evaluation of minimal residual disease in patients with chronic lymphocytic leukemia: efficacy of in vivo purging by alemtuzumab (Campath-1H). 65
Real-Time PCR and Droplet Digital PCR: two techniques for detection of the JAK2(V617F) mutation in Philadelphia-negative chronic myeloproliferative neoplasms 58
Digital droplet PCR is a specific and sensitive tool for detecting IDH2 mutations in acute myeloid leukemia patients 57
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2 55
Sorafenib Induced Complete Cytogenetic and Molecular Response in a Chronic Eosinophilic Leukemia Case with t(12;13) Translocation 54
Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia 51
TYROSINE KINASE INHIBITORS SIGNIFICANTLY CHANGE THE EXPRESSION OF POLYCOMB GENES IN CHRONIC MYELOID LEUKEMIA 47
molecular evaluation of minimal residual disease in multiple myeloma 45
quantitative molecular detection of IgH rearrangement in multiple myeloma: comparison of two innovative techniques 38
Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool 14
A new digital droplet PCR method for looking at epigenetics in diffuse large B‐cell lymphomas: The role of BMI1, EZH2, and USP22 genes 1
Totale 6.246
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.831
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.831
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020869 0 0 0 62 106 142 114 84 97 107 99 58
2020/2021570 31 40 20 19 38 31 42 44 64 45 54 142
2021/2022859 30 42 13 64 144 117 30 32 70 29 70 218
2022/20231.062 159 210 68 72 86 116 8 85 168 6 79 5
2023/2024691 59 54 97 40 77 120 37 19 9 44 22 113
2024/2025110 11 75 15 9 0 0 0 0 0 0 0 0
Totale 6.246